Dementia
Page 1 • 2 itemsGain critical insights into the global dementia drug market. Track R&D, regulatory approvals, and investment opportunities for Alzheimer's & related diseases.
CervoMed's Neflamapimod Shows Brain Volume Increase in Dementia with Lewy Bodies Trial at AAN 2026
CervoMed reports neflamapimod increased basal forebrain volume and connectivity in DLB patients, suggesting potential disease reversal in early stages.
CervoMed's Neflamapimod Shows Brain Volume Improvements in Dementia with Lewy Bodies at AAN 2026
CervoMed reports neflamapimod increased basal forebrain volume in DLB patients, suggesting potential disease reversal in early neurodegenerative stages.